Cephalon Option To Buy Biologics Firm Ception Gets The Ball Rolling For 2009, CEO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Look for Cephalon to “roll up” more assets this year while the market is good, CEO Baldino says at J.P. Morgan.